Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond

Lung cancer is the most frequently diagnosed cancer and a leading cause of cancer mortality worldwide, with adenocarcinoma being the most common histological subtype. Deeper understanding of the pathobiology of non-small cell lung cancer (NSCLC) has led to the development of small molecules that tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Karachaliou, Niki, Rosell, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197428/
https://www.ncbi.nlm.nih.gov/pubmed/25364578
http://dx.doi.org/10.7497/j.issn.2095-3941.2014.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197428/
https://www.ncbi.nlm.nih.gov/pubmed/25364578
http://dx.doi.org/10.7497/j.issn.2095-3941.2014.03.003

Ejemplares similares